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Brugada syndrome (BS) is a cardiac disorder characterized by typical electrocardiographic ﬁndings
(type 1 Brugada ECG); it is associated with a high risk for sudden cardiac death (SCD) due to ventricular
ﬁbrillation (VF). Risk stratiﬁcation is still challenging, especially in cases in which a history of cardiac
arrest or VF has not been documented. The role of programmed electrical stimulation (PES) for risk
stratiﬁcation remains controversial. In this article, I will review recent published data on the use of PES
in the identiﬁcation of high-risk patients and discuss the value of PES for risk assessment in BS.
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Brugada syndrome (BS) is a cardiac disorder characterized by a
typical electrocardiographic ﬁnding (type 1 Brugada ECG) in the
right precordial leads. Since the ﬁrst report in 1992 [1], BS has
been recognized as a cause of sudden cardiac death (SCD) due to
ventricular ﬁbrillation (VF) in middle-aged individuals, especially
men [2–7]. BS is responsible for 4% of all sudden deaths and for up
to 20% of sudden deaths in individuals without structural cardiac
disease [8]. Risk stratiﬁcation in BS is still challenging, especially
in asymptomatic cases. In general, BS patients who have been
resuscitated from documented VF should receive an implantable
cardioverter deﬁbrillator (ICD) [9]. However, for individuals withrt Rhythm Society. Published by E
trocardiogram; SCD, sudden
med electrical stimulation;
lar tachycardia;
tﬂow tract
c.jpBrugada-type ECG without documented VF, the best approach is
still unclear. The value of inducibility of sustained ventricular
arrhythmias with programmed electrical stimulation (PES) for
risk stratiﬁcation is still not clear. I have reviewed recent
published data on the use of PES for identifying high-risk patients
and discussed the value of PES for risk assessment in BS.2. Clinical evidence to support that PES predicts cardiac
events in BS
Brugada et al. were the ﬁrst to propose that inducibility of
sustained ventricular arrhythmias with PES is useful to identify
patients who are at high risk of SCD [3]. During follow-up of
patients with spontaneous type 1 Brugada ECG, they found a
signiﬁcantly higher rate of cardiac events (17%) in patients with
inducible ventricular arrhythmias than in those without inducible
arrhythmias (2%) (P¼0.007). Other series published by Brugada
et al. showed that the number of cardiac events during follow-up
was much higher (13.0%) in patients in whom ventricularlsevier B.V. All rights reserved.
Table 1
Inducibility rate of VF or VT by PES.
VF Syncope Asymptomatic P value
Brugada et al. [3] 44/54 (81%) 41/62 (66%) 45/136 (33%) 0.0001
FINGER registry [7] 16/36 (44%) 109/233 (47%) 137/369 (37%) 0.06
Kamakura et al. [6] 27/41 (66%) 31/40 (78%) 52/91 (57%) n.s.
Takagi et al. [14] 37/62 (60%) 66/91 (73%) 121/181 (67%) 0.25
VF¼ventricular ﬁbrillation; VT¼ventricular tachycardia; PES¼programmed elec-
trical stimulation; n.s.¼not signiﬁcant.
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be induced (1.1%) [10]. Subsequent data from Brugada et al. also
indicated that, in patients without previous cardiac arrest, the
incidence of arrhythmic events was signiﬁcantly higher in
patients in whom ventricular arrhythmia could be induced
(13.9%) than in those in whom it could not be induced (1.1%)
(P¼0.008), and that the inducibility of ventricular arrhythmias on
PES is an independent predictor for cardiac events (hazards ratio
[HR], 8.33; 95% conﬁdence interval [CI], 2.8–25; P¼0.0001) [11].
In 2008, Benito et al. from Brugada’s group reported a prospective
study that included 384 patients during a mean follow-up of 58
months [12]. In this study, the incidence of cardiac events was
signiﬁcantly higher (74.1%) in inducible male patients than in
noninducible male patients (27.6%) (Po0.001). Multivariate ana-
lysis revealed that the inducibility of ventricular arrhythmias on
PES is an independent predictor for cardiac events (HR, 2.93; 95%
CI, 1.14–7.55; P¼0.02). Recently, Delise et al. reported a very
interesting combined clinical and electrophysiologic approach to
risk stratiﬁcation in BS [13]. PES was performed in 245 patients
with type 1 Brugada ECG and no previous cardiac arrest. During a
median follow-up period of 40 months, major arrhythmic events
(VF or SCD) occurred in 14% of inducible patients, 0% of non-
inducible patients, and 5.3% of patients who did not undergo PES
(Po0.001). No single clinical risk factor, including positive PES,
was able to identify the patients at highest risk. However, the
patients at the highest risk were those with spontaneous type
1 Brugada ECG along with at least 2 of the following risk factors:
syncope, family history of sudden death, and positive PES. The
combination best able to predict major arrhythmic events was
spontaneous type 1 Brugada ECG, history of syncope, family
history of sudden death, and positive PES (C-statistic, 0.87; 95%
CI, 0.82–0.90).
All these published studies support the prognostic value of PES
alone or in combination with other risk factors.3. Evidence to deny the predictive value of PES for cardiac
events
In the same year that Brugada et al. reported the useful
prognostic value of PES as a predictor for cardiac events, Priori
et al. were unable to conﬁrm the predictive value of PES and
suggested that PES might lead to unnecessary overtreatment with
ICD due to the high inducible rate [2]. They performed PES in 86
patients with BS. VF or sustained polymorphic ventricular tachy-
cardia (VT) was induced in 57 of 86 patients (66%). Overall, the
sensitivity and speciﬁcity for the inducibility of VF or VT were 66%
and 34%, respectively. Kaplan–Meier analysis of cumulative sur-
vival from cardiac arrest failed to show an association between
inducibility of VF or VT and spontaneous occurrence of VF. Over
the years, other large multicenter studies, except those by
Brugada et al., failed to conﬁrm the ability of VF or VT inducibility
to identify high-risk patients [4–7,14]. Eckardt et al. performed
PES in 188 patients with type 1 Brugada ECG. During a mean
follow-up period of 40 months, 9 patients experienced an
arrhythmic event. Five of the 9 patients were inducible (56%).
Positive and negative predictive values were low (5.4 and 95.7%,
and 6.6 and 96.4%, with up to 3 or 2 extrastimuli, respectively).
Kaplan–Meier analysis showed that inducibility of VF or VT was
not a predictor of outcome of cumulative survival from cardiac
events [4]. In the FINGER study, a large multicenter European
study that included 1029 consecutive individuals, PES was per-
formed in 638 individuals (62%). Sustained ventricular tachyar-
rhythmias were inducible in 262 patients (41%). The rate of
inducible ventricular tachyarrhythmia was higher in previously
symptomatic patients (125/269, 46%) than in asymptomaticindividuals (137/369, 37%) (P¼0.02), but was not statistically
different among the cardiac arrest, syncope, and asymptomatic
groups (44%, 47%, and 37%, respectively; P¼0.06) (Table 1). In
multivariate analysis during a median follow-up period of 31.9
months, inducibility of VF or VT did not show an independent
predictive value for cardiac events (P¼0.48) [7]. Recent multi-
center large-scale prospective studies from Japan also indicated
that inducibility of VF or VT was not a predictor of cardiac events.
In a study performed by Kamakura et al. in 330 consecutive
individuals, PES was performed in 232 (70%). The inducibility rate
of VF or polymorphic VT in all patients was signiﬁcantly higher
(77/109; 72%) in symptomatic than in asymptomatic probands
(61/123; 50%, Po0.005). However, in 172 patients with type
1 Brugada ECG, the inducibility rates of VF or polymorphic VT in
the VF, syncope, and asymptomatic groups were 27/41 (66%), 31/
40 (78%), and 52/91 (57%), respectively, (not signiﬁcant) (Table 1).
In multivariate analysis, during a mean follow-up period of 48.6
months for patients with type 1 Brugada ECG, inducibility of VF or
VT was not an independent predictor for cardiac events (P¼0.54)
[6]. In our previous study in 2007, which included 188 patients,
PES was performed in 146 patients (31 VF, 52 syncope, 63
asymptomatic). VF or polymorphic VT was induced in 23 (74%),
41 (79%), and 50 patients (79%) in the VF, syncope, and asympto-
matic groups, respectively. There were no signiﬁcant differences
in the rates of inducibility among the 3 groups (P¼0.23).
Inducibility of VF or VT was not useful in predicting cardiac
events during a mean follow-up period of 37 months (P¼0.63)
[5]. In our most recent study, which included 460 patients, PES
was performed in 334 patients (62 VF, 91 syncope, 181 asympto-
matic). VF or polymorphic VT was induced in 37 (60%), 66 (73%),
and 121 patients (67%) in the VF, syncope, and asymptomatic
groups, respectively (P¼0.25) (Table 1). Similarly, inducibility of
VF or VT was not useful in predicting cardiac events during a
mean follow-up period of 50 months (P¼0.20 in all patients and
P¼0.66 in patients without documented VF) [14].
Some of these studies suggest that PES has some diagnostic
value because of a higher rate of VF or VT inducibility in
symptomatic patients than in asymptomatic individuals. How-
ever, all the aforementioned studies deny the prognostic value of
PES for cardiac events.4. Meta-analyses of previous data on BS
Two meta-analyses of previous data on BS were published in
2006 and 2007 [15,16] and evaluated the role of PES as a predictor
of cardiac events. Gehi et al. retrieved data from 30 prospective
studies (total, 1545 patients). They evaluated relative risk and risk
difference for an event (syncope, SCD, or ICD shock) for a variety
of risk factors in BS. PES was performed in 785 patients. During a
mean follow-up period of 32 months, inducibility of VF or VT by
PES was not an independent predictor for these events (HR, 1.88;
95% CI, 0.62–5.73; P¼0.27) [15]. Paul et al. analyzed 15 studies
comprising a total of 1217 patients with BS. Overall, 1036 patients
(85%) underwent PES. The rate of inducible VF or VT was higher in
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in the VF group, 55% in the syncope group, and 25% in the
asymptomatic group). During a mean follow-up period of 34
months, inducibility of VF or VT by PES did not show an
independent predictive value for the later occurrence of VF or
VT (HR, 1.5; 95% CI, 0.05–4.06; P¼0.399) [16]. With regard to the
impact of inducibility of VF or VT by PES on the occurrence of VF
or VT, they also analyzed only the data reported by Brugada et al.
and revealed a prominent difference in the ﬁndings of Brugada
et al. and those of all other studies in the meta-analysis. In the
studies by Brugada et al., the hazard ratio for the occurrence of VF
or VT was signiﬁcantly higher (HR, 10.0; 95% CI, 3.81–26.23;
Po0.0001) than that found by all other studies (HR, 0.77; 95% CI,
0.42–1.41; P¼0.364).
Both meta-analyses concluded that PES did not provide sig-
niﬁcant prediction of cardiac events in BS.5. Possible reasons for the divergent results for the predictive
value of PES for cardiac events
There are several possible reasons for the controversy over the
predictive value of PES for risk stratiﬁcation.
First, there were methodological differences in the stimulation
protocols used for PES, including the number of extrastimuli, the
minimum coupling interval used (up to 200 ms or refractoriness),
the site of stimulation (right ventricular apex [RVA] and/or right
ventricular outﬂow tract [RVOT]), and the amplitude of the
electrical impulse during stimulation. In the studies by Brugada
et al., stimulation was delivered only from the RVA with up to
3 extrastimuli, with a minimum coupling interval of 200 ms [11].
The FINGER study and 2 recent multicenter prospective studies
from Japan used a PES protocol for stimulation from the RVA and
RVOT with up to 3 extrastimuli. In the FINGER study, a minimal
coupling interval was 200 ms, whereas the Japanese studies went
up to ventricular refractoriness [6,14]. The stimulation protocol
markedly inﬂuences the extent of inducibility of VF or VT in
BS [17].
To solve this methodological issue, both a single center study
and a multicenter study were recently performed using a uniform
protocol for PES. Makimoto et al. performed PES using a uniform
protocol in 108 consecutive patients with type 1 Brugada ECG (26
VF, 40 syncope, 42 asymptomatic) in a single center [18]. A
maximum of 3 ventricular extrastimuli were delivered from the
RVA and RVOT up to ventricular refractoriness, or until the
coupling interval reached 180 ms. The basic cycle length was
500 ms. VF or VT were induced in 4 patients by a single extra-
stimulus, in 41 by double extrastimuli, and in 36 by triple
extrastimuli, and were more frequently induced from the RVOT
(70%) than from the RVA (30%). During a mean follow-up period
of 79 months, the overall inducibility of VF or VT was not
associated with an increased risk of VF (P¼0.78). However,
patients with VF or VT inducible by single or double extrastimuli
had a worse prognosis than those in whom VF or VT was
inducible by triple extrastimuli; this was signiﬁcant in all patients
(P¼0.004) and in patients without documented VF (P¼0.001).
Positive and negative predictive values of VF or VT inducible with
up to 2 extrastimuli (36% and 87%, respectively) were better than
those inducible with up to 3 extrastimuli (23% and 81%, respec-
tively). They concluded that single or double extrastimuli at PES
were adequate for a prognostic indicator in BS, and that site of
stimulation and coupling interval of extrastimuli were not prog-
nostic indicators in BS.
Priori et al. reviewed the PRELUDE prospective registry to
assess the predictive accuracy of inducibility of VF or VT by PES
performed using a uniform protocol in 10 centers [19]. A total of308 consecutive patients with type 1 Brugada ECG and without
history of cardiac arrest were enrolled. The PES protocol consisted
of 2 basic drive cycles (600 and 400 ms, S1) and up to 3 extra-
stmuli (S2–S4) delivered from the RVA and RVOT. The minimal
coupling interval of extrastimuli was set to 200 ms for S2 and S3
and to ventricular refractoriness for S4. They also assessed short-
term reproducibility of PES. In 126 of 308 patients (41%), VF or
polymorphic VT was induced. Of the 126 inducible patients, 5.5%
were induced by single, 44.5% by double, and 50% by triple
extrastimuli. The site of inducibility was equally distributed
among the RVA (46.0%), the RVOT (46.8%), and both (7.2%).
A reproducible outcome of PES was only 34%. During a mean
follow-up period of 36 months, the overall inducibility of VF or
polymorphic VT was not associated with the occurrence of
arrhythmic events (VF or appropriate ICD interventions) (3.9% in
inducible individuals vs. 4.9% in noninducible individuals,
P¼0.67). Although the stimulation protocol used in this study
was more aggressive than that in the study of Delise et al., the
negative predictive value of PES was lower than that (100%)
in Delise’s study [13]. When restricted to patients inducible
with single or double extrastimuli, inducibility of VF or poly-
morphic VT was not associated with the occurrence of arrhythmic
events either (P¼0.89). The sensitivity and speciﬁcity of VF or
polymorphic VT with up to 2 extrastimuli were 25% and 74.2%,
respectively, and 35.7% and 58.8%, respectively, with up to
3 extrastimuli. Priori et al. concluded that the inducibility of VF
or polymorphic VT had no predictive value for the occurrence of
arrhythmic events, even for PES performed with up to 2 extra-
stimuli. This conclusion agrees with the results of the 2 meta-
analyses, the FINGER study and the Japanese multicenter pro-
spective studies, but differs from the results of Makimoto et al.
Interestingly, although the inducible rate of VF or VT was identical
in the PRELUDE registry and in the study of Brugada et al. [11], the
rate of cardiac events during follow-up is much lower in the
PRELUDE registry (1.5% per year in the PRELUDE registry vs. 4.1%
per year in the study by Brugada et al.) [11]. Despite the similar
rate of inducibility with up to 3 extrastimuli, the evaluation of the
predictive value of PES was completely different.
It is possible that this contradiction may be due to referral bias
in the studies of Brugada et al. [20,21].
Second, it is possible that time of day inﬂuences the results of
PES. The magnitude of ST-segment elevation in the right pre-
cordial leads in BS varies spontaneously over days and during the
same day [22,23]. Usually, the time of maximal ST-segment
elevation is during the night. The time when PES is performed
does not generally coincide with the time of maximal ST-segment
elevation. Because the degree of ST-segment elevation is asso-
ciated with the arrhythmogenic substrate in BS, it is reasonable to
assume that the rate of inducibility of VF or VT by PES will be
higher if PES is performed at the time of maximal ST-segment
elevation.
Third, it is still very unclear whether asymptomatic individuals
with Brugada ECG should undergo PES [20,21]. One potentially
important reason for the divergent results in asymptomatic
individuals is the relatively low rate of spontaneous cardiac
events in all previous series other than the studies by Brugada
et al. Even in asymptomatic individuals with spontaneous type
1 ECG, the rates of cardiac events in most published series
are between 0% and 2.8% (mean follow-up of approximately
3.5 years). The number of asymptomatic individuals with cardiac
events during follow-up was still too small to evaluate predictors
of cardiac events, including PES. Further study is needed to
improve the understanding of predictors of cardiac events in
asymptomatic individuals with BS.
Finally, there may be the possibility that some unidentiﬁed
differences in patient characteristics, induction techniques, or
M. Takagi / Journal of Arrhythmia 29 (2013) 96–99 99follow-up protocol are responsible for the discrepant results for
the predictive value of PES for cardiac events.
In conclusion, most previous studies and 2 meta-analyses have
provided evidence of the poor utility of PES for risk stratiﬁcation
in BS. However, there is still no unequivocal explanation for the
discrepant results with regard to the role of PES for risk stratiﬁca-
tion. The limits of conventional PES should encourage investiga-
tive efforts to identify a new PES approach. At least, we should
not use the stimulation protocol that was used in the PRELUDE
registry for risk stratiﬁcation in patients without documented VF.
According to recent studies, a combined clinical and electro-
physiologic approach or stimulation protocol consisting of a basic
drive cycle of 500 ms and up to 2 extrastmuli may be useful for
risk proﬁling in BS. Further studies are warranted to evaluate the
usefulness of the new PES protocol for risk stratiﬁcation, espe-
cially in asymptomatic individuals with BS.Conﬂict of interest
There is no conﬂict of interest and no relationship with
industry.
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